海外の治験の状況「1」での検索結果
860件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy
- Non-Small Cell Lung Cancer;Non-Small Cell Lung Cancer;Non-Small Cell Lung Cancer;Non-Small Cell Lung Cancer
- Argentina, Austria, Brazil, Canada, France, Germany, Greece, Hungary, India, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Norway, Poland, Puerto Rico, Romania, Russian Federation, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom, United States
- 2010-07-16
Not recruiting
- A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib
- Hepatocellular Carcinoma;Hepatocellular Carcinoma;Hepatocellular Carcinoma;Hepatocellular Carcinoma
- Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Czech Republic, Finland, France, Germany, Hong Kong, Hungary, Indonesia, Israel, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, New Zealand, Norway, Philippines, Portugal, Puerto Rico, Romania, Singapore, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United States
- 2010-06-02
Not Recruiting
- A PROSPECTIVE, MULTICENTER, DOUBLE-RANDOMISED, DOUBLE-BLIND, 2-PARALLEL GROUPS, PHASE 3 STUDY TO COMPARE AS FIRST LINE THERAPY EFFICACY AND SAFETY OF MASITINIB IN COMBINATION WITH GEMCITABINE, TO GEMCITABINE IN COMBINATION WITH PLACEBO, FOLLOWED AS SECOND LINE TREATMENT BY MASITINIB IN COMBINATION WITH FOLFIRI 3 VERSUS PLACEBO IN COMBINATION WITH FOLFIRI 3 IN THE TREATMENT OF PATIENTS WITH NON RESECTABLE LOCALLY ADVANCED OR METASTATIC PANCREATIC CANCER
- -C259 Pancreas, unspecified Pancreas, unspecified;Pancreas, unspecified
- Brazil, Bulgaria, Chile, China, Colombia, Czech Republic, Georgia, Germany, Greece, Hungary, India, Italy, Malasya, Mexico, Morocco, Peru, Philippines, Poland, Romania, Russian Federation, Singapore, Slovakia, Spain, Taiwan, Thailand, Tunisia, Ukraine, United Kindgdom
- 2016-04-20
Not recruiting
- Open-label Trial to Evaluate the Long Term Safety of Titrated Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease
- Autosomal Dominant Polycystic Kidney Disease
- Argentina, Australia, Belgium, Canada, Czech Republic, Czechia, Denmark, Germany, Hungary, Israel, Italy, Netherlands, Norway, Poland, Romania, Russian Federation, South Africa, Spain, Sweden, United Kingdom, United States
- 2014-09-25
Not recruiting
- Multi Interventional Study Exploring HIV-1 Residual Replication: a Step Towards HIV-1 Eradication and Sterilizing Cure
- Chronic Infection;HIV
- Brazil
- 2015-12-18
Not recruiting
- The BROADEN Study: A Study of Volanesorsen (Formerly ISIS-APOCIIIRx) in Patients With Familial Partial Lipodystrophy
- Familial Partial Lipodystrophy
- Belgium, Brazil, Canada, Germany, Greece, Israel, Italy, Netherlands, Portugal, Russian Federation, Spain, Turkey, United Kingdom, United States
- 2015-08-17
Not recruiting
- Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2)
- Infection, Human Immunodeficiency Virus
- Argentina, Australia, Canada, France, Germany, Italy, Russian Federation, Spain, Taiwan, United Kingdom, United States
- 2015-04-09
Not Recruiting
- Study designed to evaluate the safety and efficacy of AMG 145, in people with elevated LDL-C and not treated with any other lipid-lowering medications.To do this, AMG 145 will be compared with placebo and with ezetimibe.
- Dyslipidemia MedDRA version: 16.1 Level: LLT Classification code 10020604 Term: Hypercholesterolemia System Organ Class: 100000004861 MedDRA version: 16.1 Level: LLT Classification code 10058110 Term: Dyslipidemia System Organ Class: 100000004861 ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Australia, Belgium, Brazil, Canada, Denmark, France, Korea, Republic of, South Africa, Taiwan, Turkey, United States
- 2012-08-24
Not recruiting
- Safety and Efficacy of Insulin NPH Compared to a New Insulin Formulation in Subjects With Type 2 Diabetes
- Diabetes;Diabetes Mellitus, Type 2
- Brazil
- 2008-02-28
Not recruiting
- Low Density Lipoprotein (LDL) Cholesterol Metabolism in Impaired Glucose Tolerance
- Impaired Glucose Tolerance
- Brazil
- 2009-11-24